RDY
Dr. Reddy’s Laboratories Ltd ADRNYSEHEALTHCAREDRUG MANUFACTURERS - SPECIALTY & GENERIC
Key Statistics
Market Cap
$11.05B
P/E Ratio
18.38
EPS
$0.72
Beta
0.29
52W High
$16.07
52W Low
$12.77
50-Day MA
$13.67
200-Day MA
$13.96
Dividend Yield
0.69%
Profit Margin
16.40%
Forward P/E
24.15
PEG Ratio
3.66
About Dr. Reddy’s Laboratories Ltd ADR
Dr. Reddy's Laboratories Limited is a globally integrated pharmaceutical company. The company is headquartered in Hyderabad, India.
Fundamentals
| Revenue (TTM) | $345.83B |
| Gross Profit (TTM) | $190.84B |
| EBITDA | $84.79B |
| Operating Margin | 16.40% |
| Return on Equity | 16.10% |
| Return on Assets | 7.96% |
| Revenue/Share (TTM) | $69.37 |
| Book Value | $0.81 |
| Price-to-Book | 2.80 |
| Price-to-Sales (TTM) | 0.03 |
| EV/Revenue | 3.071 |
| EV/EBITDA | 11.08 |
| Quarterly Earnings Growth (YoY) | -14.30% |
| Quarterly Revenue Growth (YoY) | 4.40% |
| Shares Outstanding | $832.60M |
| Float | $599.47M |
| % Insiders | 0.00% |
| % Institutions | 14.51% |
Historical Volatility
HV 10-Day
24.68%
HV 20-Day
30.71%
HV 30-Day
29.67%
HV 60-Day
25.43%
HV Rank
84.9%
Volatility is currently contracting
Analyst Ratings
Consensus ($14.17 target)
2
Buy2
Hold1
SellMore HEALTHCARE Stocks
Data last updated: 5/11/2026